Thieler Law Corp advises investors with losses exceeding $100,000 of the April 9, 2018 lead plaintiff deadline in a class action lawsuit filed against Johnson & Johnson (NYSE: JNJ) (“Johnson & Johnson” or “the Company”). The suit is pending in the U.S. District Court for the District of New Jersey and investors, who purchased Johnson & Johnson securities between February 22, 2013 and February 7, 2018, have until April 9, 2018 to move for lead plaintiff. You do not need to move for lead plaintiff to be a member of the Class.

If you purchased Johnson & Johnson securities during the Class Period, and have losses over $100,000, you may contact Thieler Law Corp by calling at (619) 377 - 4324 or emailing mail@thielerlaw.com . No class has been certified in this case, and if your losses are less than $100,000 you are still a member of the class.

The complaint alleges that during the Class Period defendants made false and misleading statements and/or allegedly failed to disclose that Johnson & Johnson has known for decades that its talc products include asbestos fibers and that the exposure to those fibers can cause ovarian cancer and mesothelioma; and as a result, Defendants' public statements were materially false and misleading at all relevant times.

On February 5, 2018, a report by CNBC revealed that “court proceedings could expose potentially damaging documents” in connection with J&J’s talc products, such as Johnson’s Baby Powder.

On this news, NYSE: JNJ fell $7.29 per share or over 5% to close at $130.39 per share on February 5, 2018.

On February 7, 2018, the Beasley Allen Law Firm revealed that “[l]awsuits filed by ovarian cancer and mesothelioma victims are revealing never-before-seen documents from Johnson & Johnson and talc supplier, Imerys, that shed light on just how prevalent asbestos and heavy metals are in the talc used in Baby Powder.” Furthermore “[i]nternal Johnson & Johnson documents from 1972 note that asbestos was found in 100 percent of talc samples tested at the time, but this information was never released publicly,” and continued to explain how J&J stopped testing talc samples for asbestos contamination after majority of the sample batches were found to be positive for asbestos.

On this news, NYSE: JNJ fell, harming investors.

If you were negatively impacted by your investment in Johnson & Johnson securities between February 22, 2013 and February 7, 2018 and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, please contact us for your no-cost evaluation.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/

or

Facsimile: +1 (619) 785 – 3185